Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 28, 2012; 18(24): 3105-3111
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3105
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3105
Mean (range) | |
Age at inclusion (yr) | 47 (22-75) |
Male sex | 63/96 |
Duration of primary sclerosing cholangitis (yr) | 12 (0-30) |
Age at primary sclerosing cholangitis diagnosis (yr) | 35 (11-65) |
Fibroscan value (kPa) | 11.1 (2.8-48) |
Undergone orthotopic liver transplantation, n (%) | 12 (12.5) |
Bilirubin (μmol/L) | 15.3 (3-82) |
Alkaline phosphatase (μkat/L) | 2.66 (0.5-12.4) |
Phosphatidylethanol (μmol/L) | 0.28 (0.1-8.4) |
Carbohydrate-deficient transferrin (%) | 1.01 (0.5-3) |
Body mass index (kg/m2) | 24.1 (17.2-34.3) |
Inflammatory bowel disease (%) | 73/96 (76) |
Smoking-current user, n (%) | 4 (4.2) |
Smoking-ex user, n (%) | 16 (16.7) |
Smoking-never used, n (%) | 76 (79.2) |
Lifetime drinking habits | |
Age at first alcohol intake (yr) | 17 (12-28) |
Lifetime alcohol intake (unit) | 3882 (0-20 270) |
Yearly alcohol intake, total (unit) | 137 (0-1180) |
Yearly alcohol intake, before diagnosis (unit) | 109 (0-674) |
Yearly alcohol intake, after diagnosis (unit) | 134 (0-1110) |
Total occasions of binge-drinking | 294 (0-4054) |
Yearly occasions of binge-drinking, total | 11.3 (0-165) |
Yearly occasions of binge-drinking, before diagnosis | 12.0 (0-295) |
Yearly occasions of binge-drinking, after diagnosis | 8.0 (0-83) |
Variable | Non-significant fibrosis (n = 70) | Significant fibrosis (n = 26) | P value |
Duration of disease (yr) | 10.1 ± 6.8 | 15.6 ± 7.9 | 0.019 |
Age at primary sclerosing cholangitis diagnosis (yr) | 36 ± 14 | 34 ± 13 | 0.29 |
Lifetime alcohol intake (unit) | 3896 ± 4441 | 3845 ± 4457 | 0.44 |
Yearly alcohol intake, mean (unit) | 144 ± 178 | 117 ± 135 | 0.27 |
Total occasions of binge-drinking | 331 ± 692 | 194 ± 341 | 0.23 |
Yearly occasions of binge-drinking | 12.7 ± 24.7 | 7.1 ± 13 | 0.41 |
Yearly alcohol intake, before diagnosis (unit) | 111 ± 129 | 103 ± 141 | 0.24 |
Yearly alcohol intake, after diagnosis (unit) | 151 ± 200 | 88 ± 86 | 0.26 |
Yearly binge drinking episodes, before diagnosis | 14.9 ± 38.1 | 4.3 ± 7.3 | 0.07 |
Yearly binge drinking episodes, after diagnosis | 9.6 ± 18.6 | 3.6 ± 4.7 | 0.23 |
Bilirubin (μmol/L) | 11.8 ± 6.8 | 24.8 ± 23.1 | 0.015 |
Alkaline phosphatase (μkat/L) | 2.66 ± 2.65 | 2.66 ± 2.22 | 0.45 |
Phosphatidyl ethanol (μmol/L) | 0.33 ± 1 | 0.1 ± 0 | 0.0016 |
Carbohydrate deficient transferrin (%) | 1.06 ± 0.38 | 0.88 ± 0.2 | 0.02 |
Body mass index (kg/m²) | 24.12 ± 3.12 | 24.02 ± 4.24 | 0.43 |
- Citation: Hagström H, Stål P, Stokkeland K, Bergquist A. Alcohol consumption in patients with primary sclerosing cholangitis. World J Gastroenterol 2012; 18(24): 3105-3111
- URL: https://www.wjgnet.com/1007-9327/full/v18/i24/3105.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i24.3105